<DOC>
	<DOCNO>NCT00092417</DOCNO>
	<brief_summary>This study compare safety tolerability profile high potency investigational vaccine investigational vaccine lower potency dose .</brief_summary>
	<brief_title>Evaluation Safety Tolerability Higher Potency Dose Investigational Vaccine Among Adults 50 Years Age Older ( V211-009 )</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy individual 50 year age old history chickenpox herpes zoster Exclusion Criteria : Preexisting condition might affect vaccine safety condition inhibit immune response</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>